首页    期刊浏览 2024年09月14日 星期六
登录注册

文章基本信息

  • 标题:Opioid peptides and alpha-melanocyte-stimulating hormone in genetically obese (ob/ob) mice during development
  • 本地全文:下载
  • 作者:J Rossier ; J Rogers ; T Shibasaki
  • 期刊名称:Proceedings of the National Academy of Sciences
  • 印刷版ISSN:0027-8424
  • 电子版ISSN:1091-6490
  • 出版年度:1979
  • 卷号:76
  • 期号:4
  • 页码:2077-2080
  • DOI:10.1073/pnas.76.4.2077
  • 语种:English
  • 出版社:The National Academy of Sciences of the United States of America
  • 摘要:Compared to littermate controls (C57BL/6J ob/?), body weights of genetically obese (ob/ob) mice are significantly higher at 1-6 months of age; the greatest percentage weight gain of the ob/ob group occurs during the first 3 months of life. Levels of pituitary immunoreactive beta-endorphin and immunoreactive alpha-melanocyte-stimulating hormone are also significantly elevated in ob/ob animals compared to controls. However, these pharmacological differences only emerge at 4-6 months of age--3 months after the appearance of obesity. High levels of immunoreactive endorphin in the pituitary are, therefore, more likely to be a consequence than a cause of obesity. Furthermore, numerous other neurologic abnormalities, which may or may not play a role in the obesity syndrome, are evident in ob/ob mice. Compared to controls, ob/ob total brain, hypothalamus, and pituitary weights are 11%, 16%, and 23% less, respectively. Levels of immunoreactive Leu5-enkephalin in pars nervous are also 200% higher in ob/ob mice; this increase is apparent at 1-6 months of age and is highly correlated with changes in body weight.
国家哲学社会科学文献中心版权所有